Crossmark

Higher (40%) versus lower (30%) FiO2 threshold for surfactant administration in preterm neonates between 26 and 32 weeks of gestational age: a non-inferiority randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s00431-025-06628-1

Published Online: 2025-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Haq, Mir Inamul

Datta, Vikram

Bandyopadhyay, Tapas

Nangia, Sushma

Anand, Pratima

Murukesan, Vishnu Mohan
License Information

Text and Data Mining valid from 2025-11-25

Version of Record valid from 2025-11-25
More Information

Article History

Received: 31 August 2025

Revised: 30 October 2025

Accepted: 8 November 2025

First Online: 25 November 2025

Declarations

:

: The trial has been prospectively registered (before the study started) in the CTRI registry, India Number (CTRI/2023/12/060562). The study has been approved by the Institutional Ethics Committee, Lady Hardinge Medical College and Associated Hospitals, New Delhi (LHMC/IEC/2023/26). The study was conducted in accordance with the ethical principles laid down in the Declaration of Helsinki (2013) and the Indian Council of Medical Research (ICMR) National Ethical Guidelines for Biomedical and Health Research Involving Human Participants (2017) and the Drugs and Clinical Trials Rules, 2019 (GSR 227(E)) of India.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below